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Abstract
Background: To clarify the role of the POU domain transcription factor Oct4 in Adipose Tissue Stromal Cells (ATSCs), we
investigated the regulation of Oct4 expression and other embryonic genes in fully differentiated cells, in addition to
identifying expression at the gene and protein levels. The ATSCs and several immature cells were routinely expressing Oct4
protein before and after differentiating into specific lineages.
Methodology/Principal Findings and Conclusions: Here, we demonstrated the role of Oct4 in ATSCs on cell proliferation
and differentiation. Exogenous Oct4 improves adult ATSCs cell proliferation and differentiation potencies through
epigenetic reprogramming of stemness genes such as Oct4, Nanog, Sox2, and Rex1. Oct4 directly or indirectly induces
ATSCs reprogramming along with the activation of JAK/STAT3 and ERK1/2. Exogenic Oct4 introduced a transdifferentiation
priority into the neural lineage than mesodermal lineage. Global gene expression analysis results showed that Oct4
regulated target genes which could be characterized as differentially regulated genes such as pluripotency markers NANOG,
SOX2, and KLF4 and markers of undifferentiated stem cells FOXD1, CDC2, and EPHB1. The negatively regulated genes
included FAS, TNFR, COL6A1, JAM2, FOXQ1, FOXO1, NESTIN, SMAD3, SLIT3, DKK1, WNT5A, BMP1, and GLIS3 which are
implicated in differentiation processes as well as a number of novel genes. Finally we have demonstrated the therapeutic
utility of Oct4/ATSCs were introduced into the mouse traumatic brain, engrafted cells was more effectively induces
regeneration activity with high therapeutic modality than that of control ATSCs. Engrafted Oct4/ATSCs efficiently migrated
and transdifferentiated into action potential carrying, functionally neurons in the hippocampus and promoting the
amelioration of lesion cavities.
Citation: Kim JH, Jee MK, Lee SY, Han TH, Kim BS, et al. (2009) Regulation of Adipose Tissue Stromal Cells Behaviors by Endogenic Oct4 Expression Control. PLoS
ONE 4(9): e7166. doi:10.1371/journal.pone.0007166
Editor: Lin Mei, Medical College of Georgia, United States of America
Received June 8, 2009; Accepted August 25, 2009; Published September 24, 2009
Copyright:  2009 Kim et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the 21st Century Frontier/Stem Cell Research Committee (SC5110) in Seoul Korea. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sookang@snu.ac.kr
. These authors contributed equally to this work.
Introduction
A critical regulator of stem cell pluripotency, Oct4 (POU
domain transcription factor, Pou5f1) is highly expressed in the
early stage of mammalian embryo and in the inner cell mass of the
blastocyst. Downregulation of Oct4 expression during trophoblast
differentiation, the generation of mutant embryos, and conversion
into exclusively trophoblast-like cells after Oct4 knockout revealed
that the transcription factor, Oct4 was required to either establish
or maintain pluripotency in the developmental embryo. For
embryonic stem (ES) cell culture, even though the mechanisms of
Oct4 involving cell fate regulation have been widely investigated,
the postnatal role is still unclear.
Recent studies have shown Oct4 to be associated with the
undifferentiated pluripotent state of stem cell populations derived
from various adult tissues. To clarify the role of Oct4 in adult cells,
we investigated the regulation of Oct4 expression and other
embryonic genes in fully differentiated cells, while identifying that
it was also expressed at the gene and protein levels in ATSCs.
Along with Oct4, Sox2 also have been identified to be crucial for
maintenance of the pluripotent state of ES cells [1,2]. ES cells lose
the capacity to maintain pluripotency upon knockdown of
expression of these transcription factors by RNA interference. It
has been demonstrated by chromatin immunoprecipitation studies
that Oct4 and Sox2 bind to a few thousand regulatory sites in the
ES cell genome [3,4] and likely that many of these target genes
play a modulating role in ES cell differentiation. In ES cells, Oct4
and Sox2 were shown to reciprocally regulate Pou5f1 and Sox2
transcription via the Oct4, Sox2 complex in ES cells [5].
Additionally, Oct4 and Sox2 positively regulate Nanog expression,
revealing that the transcriptional regulation network was working
to maintain the pluripotency of ES cells. Finally, Oct4’s early
function as a pluripotency maintaining transcription factor really
acts as a gatekeeper, preventing differentiation along the
trophoblast lineage [6–8]. A recent study about somatic cells
reprogramming with specific genes showed that Oct4, Sox2, c-
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These factors can induce reprogramming in somatic, mouse
embryonic, and adult fibroblast cells to a pluripotent state. These
four factors also have been seen to induce reprogramming in
human dermal fibroblasts [9,10]. Moreover, another group
showed that Oct4, Sox2, Nanog and Lin28 were sufficient to
establish pluripotent cells from human somatic cells [11]. On the
other hand, several studies reported that Oct4 was detected in a
variety of somatic tissue-derived cells, including bone marrow
mesenchymal stem cells and subpopulation of the other adult cells
[12,13]. Several research groups have shown Oct4 to be
dispensable for somatic stem cell function and their expression
by several biochemical experiments. The majority of these studies
concentrated on the identification and characterization of putative
‘pluripotent’ subpopulations of bone marrow-derived mesenchy-
mal stem cells (MSCs).
Cell plasticity in stem cell biology specifies the ability of stem
cells to differentiate into a variety of cell lineages; the term is also
currently applied to the ability of a given cell type to reciprocally
dedifferentiate, re-differentiate, and/or trans-differentiate in
response to specific stimuli [14,15]. Cell reprogramming signifies
the withdrawal of cells from a given differentiated state into a stem
cell-like state, a process that precedes re-entry into the cell cycle
[13]. In this study, we utilized the stemness gene Oct4 to directly
induce reprogramming of adipose tissue stromal cells (ATSC) into
more primitive stem cells overexpressing stemness genes including
Oct4, Sox2, and Nanog. Additionally, demethylation of the
regulatory regions of stemness genes finally resulted in improved
stem cell behavior of de-differentiated ATSC. Proliferation activity
of reprogrammed ATSCs was induced by REX1, Oct4, and JAK/
STAT3 directly or indirectly. Oct4/ATSCs showed increased
migration activity that mediated by P38/JUNK and ERK
phosphorylation. Moreover, the regenerative efficacy of Oct4/
ATSC after engraftment into the traumatic injured brain was
significantly restored their functions. Finally, our stem cell
remodeling system may provide insight into the molecular
mechanisms underlying ATSC proliferation and transdifferentia-
tion. Also, these multipotent stem cells can potentially be harvested
to provide a reservoir of primitive and autologous stem cells for use
in a broad spectrum of regenerative cell-based disease therapy.
Results
Exogeneous Oct4 prominently improves ATSCs cell
proliferation and differentiation potencies
To determine the expression of several stemness genes in tissue
specific stem cells such as fetus-derived adult stem cells and
mesenchymal stem cells, we performed western blot analysis and
immunocytochemistry on cultured stem cells. As shown in Fig. 1A,
several control adult stem cells highly expressed Oct4, Sox2, and
Nanog. Oct4 expression in ATSC was higher than other stem cell
species.
Oct4 overexpression in ATSC as evidenced by various cell
reprogramming behaviors via the expression of stemness
genes
The control ATSCs underwent a progressive reduction in
proliferation potential, and finally underwent senescence after
passage 25–30 (78–90 days in culture). As shown in Figure 2, after
3 days of in vitro culture, the Oct4/ATSCs expressed several
stemness genes with extended cell growth. And Oct4/ATSCs
overexpressed the oncogenic gene, c-myc with prominently
extended the S phase in cell cycles (Fig. 1C). Oct4-overexpressing
ATSCs induced a 1.5-fold increase in colony formation with
increased synthetic DNA and telomerase activity along with
slightly extended telomere lengths (Fig. 1D). The Oct4-overex-
pressed ATSC cells showed prominent effects on upregulation of a
Figure 1. Oct4 actively enhances the proliferation of ATSC cells along with the overexpression of pluripotency related genes and
telomerase activation. (A) Oct4 and several stemness genes expression in various kinds of adult stem cells. (B) The proliferation activity of Oct4
overexpressed ATSC cells. Oct4 was prominently enhances ATSC cells growth activity compare to Sox2 and Nanog genes. And knockdown of
endogeneously expressing Oct4 prominently decrease cell proliferation activity and cell survival at a various siOCT4 concentration. (C) Cell cycle
analysis in exogenic Oct4 expression and differential expression of checkpoint regulating gene expression in Oct4/ATSCs. For flow cytometric
analysis, cells were cultured at densities that ensured exponential growth at the time of harvesting. Harvesting and processing protocols were used
to detect DNA via flow cytometry with propidium iodide. The percentages of cells in the G0/G1, S, and G2/M phases of the cell cycle were determined
using a DNA histogram fitting program. A minimum of 10
4 events/samples was collected. (D) Telomerase activity and telomere length analysis. Oct4/
ATSCs showed extended telomere length along with increased telomerase activity compare to control ATSCs. (E) Determination of differential
expression of stemness and several pluripotency related genes by western blotting and real time RT-PCR. (F) Tumorigenic potency and three germ
layer developing teratoma formation of Oct4/ATSCs.
doi:10.1371/journal.pone.0007166.g001
Oct4 Regulation in ATSC cells
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CDK2 and CDK4, and telomere reverse transcriptase (TERT;
Fig. 1D). We evaluated the expression of Oct4 (POU5F1) to
determine whether exogenic Oct4 induced the expression of early
developmental genes KLF4, Sox-2, Rex-1, Utf1, Dapp5, FGF4,
ERas, and Nanog in cultured ATSCs (Fig. 1E). Moreover, most of
the Oct4 target genes were upregulated including Rex1, Nanog,
and Sox2 (Fig. 1E). When Oct4/ATSCs were engrafted in the
postnatal mouse brain, engrafted cells showed a strong tumori-
genic potency in vivo (Fig. 1F). Engrafted Oct4/ATSCs presented
highly neurogenic behavior in the fetal mouse brain 2 months after
engraftment (Fig. 1F). Moreover, engrafted Oct4/ATSC cells in
SCID/NOD mice formed the traditional teratoma morphology
after 2–3 (n=4) months. Oct4/ATSC-derived teratoma tissue
developed into the three germs layers that tissues or organs such as
endocrine gland tissue, muscle, and neural cells (Fig. 1F).
Oct4 effectively induces ATSC reprogramming with JAK/
STAT3 and ERK1/2 activation and Rex1 and Oct4
upregulations
In an effort to identify the potential signaling molecules involved
in active cell proliferation following Oct4 overexpression, the total
protein levels and phosphorylation status of ERK1/2 that well
known cell proliferation mediator was assessed in the Oct4/
ATSCs. Representative ES cells growth activating signal media-
tors, JAK/STAT3 and ERK1/2 phosphorylation was clearly
upregulated at 12 hours (P,0.05) after exogenic Oct4 expression.
Coinciding with Oct4/ATSCs proliferation, phosphorylated Akt
was activated and was markedly increased after exposure to
exogenic Oct4 expression in the Oct4/ATSCs (Fig. 2A). As
following experimental results, Oct4/ATSCs proliferation was
actively mediated by JAK/STAT3 and ERK1/2 phosphorylations
(Fig. 2A). On the other hand, when we treated with PI3Kinase
inhibitors, Akt and mTOR phosphorylations were decreased
profoundly (Fig. 2A). As shown in Figure 2A, phosphorylated Akt
was significantly upregulated after exogenic Oct4 expression.
Oct4-induced ATSCs prominently activated AKT, MEK, MEKK
and potentially raf proteins during cell proliferation, and also
induced a profound reduction in ERK1/2 and p38 activation and
cell growth activity following treatment with specific inhibitors
(Fig. 2A). For further study on Oct4’s role in the proliferation of
ATSCs, the ATSC were transfected with Oct4 siRNA prior to and
after induction of exogenic Oct4 expression. Akt, PI3K, ERK1/2,
JAK, and STAT3 were also downregulated with the attenuation of
cell proliferation by Oct4 inhibition (Fig. 2A). Moreover, the
exogenic Oct4 induced cell survival after H2O2 exposure was
shown to be regulated by the downregulation of p38/JUNK
phosphorylation along with the survival signal mediator Bcl2
overexpression and apoptotic signal proteins downregulation such
as Bax, Cytochrome C, and c-PARP along with Caspase3, 8, 9
inactivations. And P38/JUNK-mediated apoptotic cell death was
prevented by inhibition of their phosphorylation (Fig. 2B).
Following the Oct4 knockdown experiment, Oct4 was shown to
be actively involved in cell proliferation and survival against
external chemical stresses after exogenic Oct4 induction (Fig. 2B).
Defective DNA methylation of stemness genes in
exogenic Oct4 induced ATSCs
The analysis of gene expression levels indicated that ,4% of the
total genes was expressed greater than 2.2-fold for different levels
in ATSC and Oct4/ATSCs. A comparison of the expression of
these showed that the cell proliferation-associated genes were
prominently upregulated in Oct4/ATSCs (Table S1, 39%). In an
effort to determine whether Oct4 overexpression was capable of
eliciting epigenetic modifications on exogenous chromatin tem-
plates of Oct4 and the other controllable stemnesses, Sox2, Nanog
and Rex1. We evaluated changes in DNA methylation pattern in
the stemness genes, Oct4, Sox2, Rex1, and Nanog promoter
Figure 2. Exogenic Oct4 induced cell proliferation and survival related signal proteins expression in Oct4/ATSCs. (A) The involvement
of JAK/STAT3, ERK1/2, MEK, and inhibition and activation resulted in prominent cell growth attenuation. Oct4 downregulation prominently induces
inactivation of JAK/STAT3, AKT, MAPK, mTOR, and c-myc. When we treated with PI3K and ERK1/2 inhibitors, associated cell growth signal mediators
and cell proliferation was decreased profoundly. For Western blotting, equal amounts of protein extracts were subjected to 10% SDS-PAGE analysis
and transferred to nitrocellulose membranes. Optimally diluted antibodies were incubated with the membranes. The relative band intensities were
determined using Quality-one 1-D Analysis software (B) Inhibition of Oct4 expression induced P38, SAPK/JUNK and mitochondria involving apoptotic
ATSC death. Treatment of siOct4 actively induced apoptotic mediators such as caspases 8 and 9 and prominently increased apoptotic cell death
along with highly increased Bax, PARP, and Cytochrome C expression or activation and Bcl2 downregulation.
doi:10.1371/journal.pone.0007166.g002
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to establish the 59-39 CpG methylation profiles across each test
gene proximal promoter, the proximal enhancer, and the early
transcription start site (TSS). In the case of Rex1, converting the
potentially methylated CpG dinucleotides occurred within 2590
to 285 nucleotides relative to the TSS (Fig. 3). For the Oct3/4
promoter encompassing the CpGs, 257 to +66 nucleotides
relative to the TSS was analyzed (Fig. 3). The proximal Sox2
and the TSS regions did not significantly alter the methylation. We
also assessed three regions of the Nanog promoter, encompassing a
total of 3 CpGs within 21503 to 2163 nucleotides relative to the
TSS. The Rex1 region assessed was methylated in the control
ATSCs and was meaningfully demethylated (Fig. 3). These Oct4
methylation patterns was prominently downregulated in the Oct/
4/ATSCs compared to the control ATSCs (Fig. 3). Finally,
exogenic Oct4 overexpression effectively induces Sox2, Nanog,
and Rex1 demethylation. Our study has also provided some
additional observations regarding nuclear remodeling, including
the acetylation of histone H3 (Fig. 2A).
Global gene expression analysis and transcriptional
regulation
To identify genes with altered expression levels before and after
Oct4 overexpression in cultured ATSCs, transcriptional profiles
were generated by using a cDNA microarray consisting of 20,000
resequenced and annotated clones. We compared the 48 hour
replicate after Oct4 overexpression with EGFP knockdown using
statistical tests for differential expression. Among differentially
expressing genes, almost 7,000 (75%) genes were overexpressed,
and another 4,600 (25%) genes were downregulated. Both sets of
markers genes were at a 0.5 significance level. These differentially
regulated marker genes could be characterized regulated target
genes by Oct4 such as pluripotency markers NANOG, SOX2, and
KLF4 and markers of undifferentiated stem cells FOXD1, CDC2,
and EPHB1. The negatively regulated genes included FAS,
TNFR, COL6A1, JAM2, FOXQ1, FOXO1, NESTIN, SMAD3,
SLIT3, DKK1, WNT5A, BMP1, and GLIS3 which were
implicated in differentiation processes as well as a number of
novel genes (Table S1). To confirm the negatively regulated
downstream targets of Oct4, the profile analysis was repeated for
BMP4. The gene encoding BMP4 is also highly expressed in the
human trophectoderm [16] and has been shown to promote
human embryonic stem cell differentiation into trophoblasts [17].
Included in this set were genes implicated in ESC differentiation,
such as the transcription factors ID3, TBX18, GATA6, and
HLX1 [18], and signal transduction pathways crucial for the
maintenance of pluripotency, such as WNT (DKK1, FRZB,
FZD2), transforming growth factor (TGF-b), and FGF (FGF8);
Figure 3. Evaluation of epigenetic modifications through methylation analysis of the promoters regions of Oct4, Rex1, Sox2, and
Nanog genes. (A) Evaluation of epigenetic modifications through methylation analysis on promoter regions of Oct4, Sox2, Rex1, and Nanog
through bisulfite modification and sequencing of genomic DNA. The related method was explained in supplementary materials and methods section.
(B) Differential expression pattern of epigenetic reprogramming related genes such as hMyst3, hSET, hSETDB 1, and hSMARCAD 1 before and after
Oct4 overexpression was detected by RT-PCR.
doi:10.1371/journal.pone.0007166.g003
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COL4A1, LOXL4, and CLDN4, which encodes a tight junction
protein crucial for trophectoderm formation. Differential expres-
sion of selected genes was verified independently using real time
PCR and prepared from Oct4 overexpressed ATSCs or control
ATSCs (Fig. 4). Confirmation of the differential expression of
genes was verified and shown in Figure 4. This revealed that the
upregulation of key pluripotency-controlling genes, OCT4,
SOX2, and NANOG, and ES-associated genes KLF4, CEBP,
FOXD1, HMGA1, and DNER. Differentially regulated genes are
listed in Table S1.
Regulatory miRNA expression in Oct4/ATSCs
We evaluated differentially expressing mature miRNAs in Oct4
overexpressed ATSCs. After global normalization of the raw data,
880 differentially expressed miRNAs were identified between
control and Oct4/ATSCs using a cut off p value of ,0.01 to
narrow down the candidates. Among these miRNAs, 208 were
significantly up- or downregulated in Oct4 overexpressed ATSCs
(p,0.00032). After global normalization, hierarchical clustering
analysis based on differentially expressed miRNAs generated a tree
with clear distinction between control and Oct4 ATSCs (Fig. 4B).
MiRNAs highly differentially expressed in Oct4/ATSCs were as
follows; let 7, mir 170, mir 132 (upregulated in Oct4/ATSCs) and
let 17 and let 120 (downregulated in Oct4/ATSCs). Correlation of
the coefficiency of total miRNA expression in both of cell groups
showed r=0.91 (Range: 21#r#1) (Fig. 4B). To validate the
results of our miRNA array analysis, 6 miRNAs were selected as
up- and down-regulated miRNAs in Oct4 transfected ATSC cells
by real time RT-PCR.
Exogenic Oct4 introduces neural transdifferentiation
priority but prominently attenuates mesodermal
differentiation
ATSCs have been identified as skeletal tissue progenitors, and
differentiate into osteoblast-like cells in cultures supplemented with
ascorbic acid with a glucocorticoid source. Calcium and lipid
droplets begin to accumulate in ATSCs following 2–4 weeks of
Figure 4. Differentially expressed mRNA and miRNA profiles in Oct4/ATSCs. (A) Global gene expression patterns were compared between
control ATSCs and Oct4/ATSCs with DNA microarray. Blue lines indicated that twofold changes in gene expression levels between the paired cell
types. Verification of differentially expressed genes in Oct4/ATSC cells (lower panel). (B) The heat map of the different expressed genes between
control (Con) and Oct4/ATSCs (O). Positions of several genes including Sox2, FOXD1, and Oct4 and miRNA in scatter plots are indicated. Correlation
Coefficiency value of the expression of miRNA in Oct4/ATSCs and control ATSCs was about 0.91. Several miRNA including mir132, mir170, and let7
were highly upregulated after Oct4 overexpression in ATSCs. In contrast of that, mir17 and mir120 was dramatically downregulated in Oct4/ATSCs.
The gene expression levels were normalized using the RMA algorithm.
doi:10.1371/journal.pone.0007166.g004
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studied the effect of Oct4 overexpression on mesodermal lineage
differentiation into fat, bone, and chondrocyte of ATSCs. Oct4
knockdown ATSCs were shown to accumulate significant
quantities of calcium and lipid droplets, and differences were
apparent in the efficiency of nodule and lipid droplet formation
between the naive and siOct4/ATSC. As shown in Figure 5A, up
to three times as many lipid droplets and nodules were detected in
siOct4/ATSCs compared to the control. After culturing siOct4/
ATSCs (passage 5) in osteogenic differentiation media, cells were
stained for calcium deposits. These results were generally
consistent with what has been observed in conjunction with the
overexpression of adipogenesis- and osteogenesis-related transcrip-
tion factors, including RXR, osteonectin, AP, and PPAR-gamma,
after Oct4 mediated cell reprogramming (Fig. 5A). Moreover,
when mesodermal differentiation was induced of Oct/4, Sox2,
and Nanog overexpressed ATSCs, the differentiation efficiencies
of each gene was prominently decreased along with each lineage
specific (Fig. 5A and 5B). To determine the transdifferentiation
activity of the Oct4/ATSC, the neurogenic potency was evaluated
through transdifferentiation into a neural lineage. After neural
induction in differentiated Oct4/ATSCs, we observed an extreme
upregulation of TuJ and MAP2ab and low levels of Nestin
expression in Oct4/ATSCs after neural differentiation and also
neurosphere formation efficiency was higher than control ATSCs
(Fig. 6A). When we engrafted Oct4/ATSCs in the fetal mouse
brain, the engrafted cells effectively transdifferentiated into TuJ-
and NF160-positive neurons in contrast of that of control ATSCs 5
weeks after engraftment (Fig. 6D). A large population of
differentiated Oct4/ATSCs showed phenotypic characteristics of
astrocytes (GFAP), and neurons (MAP2ab and NF160 [approx-
imately 45–60% of the total population]; Fig. 6D). The siOct4/
ATSCs did not appear to have neurogenic morphology and neural
gene expression 7–10 days after neural differentiation induction
(data not showed).
Exogenic Oct4 induced improved regeneration activity in
brain trauma with high therapeutic modality
To determine the regenerative activity of Oct4/ATSCs for in vivo
brain trauma, we evaluated the neurogenic potency through
transdifferentiation of the Oct4/ATSCs. After neural induction,
Oct4/ATSCs differentiated into neural cells expressed higher levels
of TuJ than in differentiated control ATSCs (Fig. 7A). Extremely
down-regulated Nestin expression was observed in Oct4-induced
neural cells after induction (data not showed). Moreover, in in vivo
lesion sites of injured brains, TuJ-positive neuron subpopulations
generally survived or actively trans-differentiated into neurons after
Oct4/ATSC engraftment (Fig. 7A). Immunohistochemical analyses
of brains with traumatic injuries revealed that a large population of
differentiated neural cells from Oct4/ATSCs displayed morpho-
logical and phenotypical characteristics of neurons (TuJ; approx-
imately35–40%ofthetotalpopulation)withhighlyimprovedrotor-
rod activity (data not showed).
Functional analysis of the neuronal properties of Oct4/
ATSCs in vitro
To confirm that adult human Oct4/ATSCs were differentiating
into functionally active neurons, electrophysiology was performed
onengraftedtraumaticbrainslices(Fig.7).Thepresenceoftheionic
currents was first investigated by applying voltage ramps between
120 and 120 mV to the patch clamped cells using a K-based pipette
solution. Engrafted brain slices with control ATSCs did not display
an inward current, whereas the brain slices with Oct4/ATSCs
actively produced a current (Fig. 7B). This current was partially
(75%) blocked by 30 nM tetrodotoxin (TTX), although 300 nM
TTX blocked it completely (Fig. 7B). This confirmed that Oct4/
ATSCs engrafted brain slices expressed voltage-gated Na channels.
Voltage-clamp recordings were performed at 70 mV in an
extracellular solution containing 3 mM Mg2. Traces showed
spontaneous slow and fast currents indicating that the transplanted
Figure 5. Effect of exogenic Oct4 and several stemness gene expressions on adipogenic, osteogenic, and chondrogenic
differentiation potencies. (A) Oct4 knockdown actively induces adipogenic, osteogenic, and chondrogenic differentiation. Differentiation potency
was evaluated by fat, bone, and chondrocyte staining and lineage specific gene expression pattern by RT-PCR or western blotting using tissue
specific markers. (B) Exogenic stemness genes expression affect on mesodermal differentiation potency. After differentiation induction of Oct4/ATSCs
and control ATSCs, the number of positive clones was quantified after fat (Oil Red O), bone (Van Kossa), and chondrocyte staining (Van Gieson) and
data presented relative density of positive population (%). (C) Effect of stemness genes overexpression on differentiation of ATSCs into bone, fat, and
chondrocyte and their lineage specific gene expression analysis after differentiation induction.
doi:10.1371/journal.pone.0007166.g005
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current was 98% blocked by CNQX AP5 solution (Fig. 7B).
Engrafted Oct4/ATSCs had efficiently migrated and transdiffer-
entiated into functionally active neurons in the hippocampus that
actively promotes the amelioration of the lesion cavity (Fig. 7C).
Discussion
Pluripotency factors, including stemness genes, provide funda-
mental mechanisms underlying the properties of stem cells. Several
factor mediated molecular pathways also engage in cross-talk with
one another in order to maintain or obtain stem cell pluripotency.
It has been shown that Oct4, Sox2 and Nanog co-regulate certain
genes encoding components of signal pathways controlling stem
cell behaviors such as cell proliferation or differentiation. They
also actively regulate chromatin remodeling via histone modifying
complexes, such as MYS3 and SET [19]. According to several
recent studies, the pluripotency factor genes are subjected to
epigenetic regulation, cell growth and differentiation behaviors via
epigenetic reprogramming. Several genes are related to epigenetic
Figure 6. The transdifferentiation potency of Oct4/ATSCs to a neural lineage in vitro and in vivo. (A) Overexpression of several stemness
genes enhances increased neurosphere formation. Neurospheres were counted after genes transfected ATSCs suspended in NB media culture and
compared to the number of neurospheres derived from control and stemness overexpressed ATSCs. (B) Comparison of neural differentiation
efficiency after neural differentiation induction between control ATSCs and Oct4/ATSCs. After neural differentiation, differentiation efficiency was
evaluated by immunocytochemistry using anti-Tuj, anti-NF160, and anti-GFAP antibody and fluorescence-tagged secondary antibodies and we also
analyzed stemness genes and neural specific gene expression pattern through (C) western blotting analysis. (D) Evaluation of in vivo integration and
neurogenesis of engrafted Oct4/ATSCs in postnatal mouse brain using the immunohistochemistry method. Arrows indicate differentiated Oct4/
ATSCs into MAP2ab-positive neurons.
doi:10.1371/journal.pone.0007166.g006
Oct4 Regulation in ATSC cells
PLoS ONE | www.plosone.org 7 September 2009 | Volume 4 | Issue 9 | e7166regulation, including Jmjd1a and Jmjd2c which are downstream
targets of Oct4 [20,21].
As a member of the POU transcription factor family, Oct4
contains a bipartite DNA binding domain consisting of two
subdomains connected by a flexible linker of varying length.
Recently, it has been reported that Oct4 activates fibroblast
growth factor 4 (FGF4), osteopontin adhesion molecule, transcrip-
tion coactivator Utf1, and transcription factor Rex1. An enhancer
element of the FGF4 gene is activated by Oct4 in cooperation with
the high mobility group box transcription factor Sox2 [22–25].
The mechanisms involved in the Oct4 regulation in ES have been
widely investigated, but the adult stage (including postnatal and
fetus stages) of Oct4 function has not been identified even though
it had recently been associated with the undifferentiated
pluripotent state of stem cell populations derived from various
adult human tissues or organs such as bone marrow-derived
multipotent adult progenitor cells. Additionally, CD133-positive
pluripotent progenitors isolated from cord blood have also been
found to be an Oct4 positive population, with a significant
reduction in expression following endothelial cell differentiation in
vitro [26].
Recently, RNAi-mediated gene knockdown was used to extend
the analysis of Oct4 function to human ATSCs. It was found that
Oct4 knockdown in ATSCs led to a decrease in stem cell identity
and increased differentiation into a mesodermal lineage, but that
also led to a decrease in neural differentiation ability of ATSC cells
at the morphological and molecular levels. Additionally, Oct4
knockdown dramatically led to apoptotic cell death of cultured
ATSC cells along with inducing the activation of apoptotic genes
such as Caspase 3 and 9 and Bax and c-PARP expressions. When
Oct4 expression was recovered by exogenic Oct4 gene overex-
pression in damaged cells, ATSCs recovered to normal and viable
cell with cell survival related signal pathway molecule such as Akt/
PI3K, Bcl2, and ERK1/2. This demonstrates that Oct4 is essential
Figure 7. The therapeutic efficacy of engrafted Oct4/ATSCs in a mouse model of a traumatic brain injury. (A) High neuroregenerative
potency of Oct4/ATSCs in injured lesion of traumatic mouse brain. The arrows indicate engrafted and functionally transdifferentiated neurons in the
hippocampus. (B) Electrophysiological properties of transdifferentiated neuron from engrafted Oct4/ATSCs from a lesion of traumatic injured brain slice.
Whole-cellpatch-clamprecordings ofengraftedOct4/ATSCsintraumatic brainslice.Thepresenceofthe ioniccurrentswas firstinvestigatedbyapplying
voltage ramps between 120 and120 mV to the cells patch clamped using K-based pipette solution. ATSCs control engrafted brain slice does not display
inward current, whereas Oct4/ATSCs engrafted brain slice actively produced a current. This current was approximately 75% blocked by 30 nM
tetrodotoxin (TTX), although 300 nM TTX blocked it completely. Oct4/ATSCs engrafted brain slice express voltage-gated Na channels. Voltage-clamp
recording at70 mV in extracellular solution containing 3 mM Mg2. Traces show spontaneous slow and fast currents that indicate that this transplanted
Oct4/ATSCs receives synaptic contacts from host cells. This current was approximately 98% blocked by CNQX AP5 solution. (C) The Oct4/ATSCs
engrafted traumatic brain demonstrated that there was a decrease in the lesion cavity size.
doi:10.1371/journal.pone.0007166.g007
Oct4 Regulation in ATSC cells
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role in maintaining pluripotency in mammals. Several previous
studies have shown that even tissue specific somatic cells can de-
differentiate into progenitor cells capable of acquiring different
functions such as pluripotency. In our study, Oct4/ATSCs
overexpress not only Oct4, Sox-2, Nanog, and Rex1, but also c-
Myc to obtain active self-renewal activity with pluripotency after
exogenic Oct4 transfection. On the other hand, Oct4/ATSC
exhibited prominent p21 and p53 gene downregulation. Our
results showed that Oct4/ATSC can increase developmental
potential following reprogramming via the overexpression of the
embryonic transcription factors, Rex1, Oct4, and Oct4-dependent
Nanog and Sox2. Most notably, Oct4/ATSC reprogrammed
somatic nuclei to express the POU family member Rex1 via DNA
demethylation. Thus, the components of pluripotent ATSCs have
the potential to elicit reprogramming events in a somatic genome.
The proliferation of Oct4/ATSCs is promoted significantly by
supplementation of exogenic Oct4 with highly improved transdif-
ferentiation activity. The results of these studies indicate that
ATSCs possess their own multipotency to reprogram into more
primitive stem cells, with the exception of chromosomal
abnormalities and point mutations (data not showed). Thus, the
exposure of Oct4/ATSCs may provide a good in vitro model to
demonstrate the mechanisms of re-differentiation from Oct4/
ATSC, which would provide insight into the molecular mecha-
nisms of ATSC proliferation. Although the ERK MAPKs
generally regulate cell growth and differentiation, and the JNK
and p38 family MAPKs preferentially mediate stress, there is now
an increasing amount of evidence to suggest that the activation of
the ERK/MAPKs can also be stimulated by a variety of stress
stimuli [14,27–29]. Our recent study indicated that exogenic Oct4
can activate MEK and ERK1/2 following the induction of de-
differentiation. Such a change was also detected with Akt
activation. This study showed for the first time that transcription
factor Oct4 could induce a reversible change of ATSCs to a more
immature reprogrammed state, via the PI3K/Akt-mediated
pathway and JAK/STAT3-mediated signals (Figure S1). The
proliferation-associated signal pathway with a high level of TERT
activity and conserved telomere length occurring in Oct4/ATSCs
and their gene expression revealed a reversion toward a more
immature phenotype. These results provided some insight into the
manner in which human ATSC gene expression responds to
exogenic Oct4 treatment.
In our study, the introduction of exogenic Oct4 to autologous
ATSCs provides a simple method for the production of primitive
stem cells via enhanced growth activity and multipotency, and
may also be utilized in the investigation of the mechanisms
underlying differentiation and cell reprogramming. As an in vivo,
traumatic brain injury model, Oct4/ATSC has dramatic regen-
erative ability with improved function. With the highly improved
growth activity, differentiation potency also specified by the de-
differentiation processes of adult stem cells, and the relative ease
with which these multipotent stem cells can be obtained, there is
potentially a large reservoir of therapeutic stem cells for use in
improved cell-based disease therapies.
Materials and Methods
Culture of human adipose tissue-derived stem cells
Human raw fat tissue obtained from the patient abdomen (as
following patient’s approval document) was processed according to
established methodologies to determine stem cell vascular function
[30]. This work was approved by Seoul National University
Institutional Review Board (IRB No. 0603/001-002-07C1) and
the ethics committee specifically approved that procedure. To
isolate stromal cells, the samples were digested at 37uC for 30 min
with 0.075% collagenase TypeIV. Enzyme activity was neutralized
with a-modified Eagle’s medium (a-MEM), containing 10% fetal
bovine serum (FBS) and centrifuged at 1,2006 g for 10 min.
Medium was replaced first at 48 hrs and then every 4th day
thereafter. Cell viability was evaluated via visual cell counts in
conjunction with trypan blue exclusion. In all viability assays,
triplicate wells were used for each condition, and each experiment
was repeated at least three times. Raw data from each experiment
were analyzed using analysis of variance with Fisher or t test.
5-Bromo-29-deoxyuridine incorporation
The proliferation activity of cultured ATSC cells was measured
by their uptake of 5-bromo-29-deoxyuridine (BrdU) using a
commercial kit (BD Pharmingen). Briefly, cells were incubated
for 24 h in growth media supplemented with 10 mM BrdU (Sigma,
Deisenhofen, Germany). In 24 h and 48 h after Oct4 transfection
(5–8 ug/ml), ATSC cells were fixed using 4% paraformaldehyde
for 15 minutes and then immunostained using an anti-BrdU
antibody according to the manufacturer’s instructions. Fluores-
cence was monitoring using an inverse confocal laser scanning
microscope (LSM 5, Pascal, Carl Zeiss, Jena, Germany). Relative
cell proliferation was calculated from the fluorescence of 5 fields of
view (n=4 for each condition). Differences in relative cell
proliferation were assessed by two-way ANOVA followed by a
post-hoc t-test. Differences between two conditions at P#0.05 and
P,0.001 was considered statistically significant.
Non-radioisotopic Telomerase Assay
Telomerase activity was assessed using a modified telomeric
repeat amplification protocol (TRAP) assay, in accordance with
the manufacturer’s instructions (BD Science). Protein extracts
were prepared from the ATSC controls and the de-ATSC. Protein
extracts (0.5 mg) prepared from each cell line was incubated in the
presence of synthetic oligonucleotide (telomerase-specific primer,
59-AATCCGTCGAGCAGAG TT-39), which could be the
substrate for the addition of telomeric repeats by telomerase. If
telomerase activity was detected in the extracts, the oligonucleo-
tide was elongated and could function as a template in subsequent
polymerase chain reactions (PCR). PCR was conducted in the
presence of nucleotides, and the formation of the amplification
products was assessed via the monitoring of telomerase repeat
amplification. PCR reaction products were separated on 12.5%
non-denaturing acrylamide gels and stained using Syber-Gold dye
(Molecular Probes, Eugene, OR, USA). Quantification of
telomerase for comparisons with telomerase activity in the Oct4
transfected ATSC and the ATSC controls was conducted via the
PCR enzyme-linked immunosorbent assay procedure suggested by
the manufacturer (BD Science).
Small interfering RNA inhibition experiment
For Knock-down experiment against Oct4 synthesized siRNA
duplex was obtained from DHARMACON. For transient
transfection, about 60% confluent cells in 6-wells were transfected
with 10 mM siRNA using Lipofectamine (Invirogen). Cells were
allowed to stabilize for 48 h before being used in experiment. Cells
were harvested after 24 hours for RNA isolation. Silencer
Negative Control siRNA (catalog number 4611; Ambion, Inc.)
was utilized as a control for non-specific gene silencing. The
transfection of siRNAs was conducted using DharmaFECT siRNA
transfection reagents, in accordance with the manufacturer’s
instructions (Dharmacon RNA Technologies). Two complemen-
tary hairpin siRNA template oligonucleotides harboring the 21 nt
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transfection using 50 nM siRNA. Furthermore, the quantity of
siRNA was optimized in accordance with the manufacturer’s
instructions. Three separate Rex1 siRNAs (SilencerH predesigned
siRNAs; Ambion) and scrambled siRNAs with the same nucleotide
content were assessed. When compared with unrelated control
siRNAs and scrambled siRNAs, the Rex1 siRNAs resulted in an
80–90% reduction in Rex1 mRNA levels, as determined via real-
time PCR. The siRNA that provided the most efficient inhibition
(90–95%) was utilized for the experiments. The inhibition of
ATSC growth was detected by transfection of Oct4 siRNA into
ATSCs cells and counted dye-exclusive viable cells for 6 days.
TUNEL Assay
The death of apoptotic cells after H2O2 treatment was estimated
in terms of their ability to reduce the dye MTT (3, 4, 5-dimethyl
thiazol-2-yl) -2, 5-diphenyl tetrazolium bromide (Sigma) to blue
purple formazan crystal. The effect of H2O2 on the induction of cell
death was determined with the TdT in situ apoptosis detector kit
(Roche, USA), used according to the manufacturer’s specifications.
After fixation, cells with 4% paraformaldehyde were incubated in
TUNEL reaction mixture containing deoxynucleotidyl transferase
(TdT) buffer with TdT and biotinylated dUTP, incubated in a
humid atmosphere at 37uC for 90 min, and then washed with PBS.
The cells were incubated at room temperature for 30 min with anti-
horseradish peroxidase-conjugated antibody, and the signals were
visualized with diaminobenzidine. The results were analyzed using a
FluorescenceMicroscope(LeicaMicrosystem,PA).TUNEL-positive
apoptotic cells were quantified by counting of positively stained cells.
Three digital microscopic images at a magnification of 1006were
randomly captured at the areas where the positive cells and the
number of positively stained cells in the three images were averaged.
Bisulfite modification and sequencing of genomic DNA
Firstly, isolation and purification of Genomic DNA was
performed through phenol/chloroform extraction and ethanol-
precipitation processes. Bisulfite conversion was conducted using
the EZ DNA Methylation–Gold Kit (Zymo Research, USA), as
indicated by the manufacturer. Briefly, unmethylated cytosines in
DNA were converted into uracil via the heat-denaturation of DNA
and with a specifically designed CT conversion reagent. DNA was
then desulphonated and subsequently cleaned and eluted. The
bisulfite-modified DNA was then immediately utilized for PCR or
stored at or below 220uC. The PCR reactions were conducted in
a MyGenie 96 Gradient Thermal Block (Bioneer, Daejeon, South
Korea) in accordance with the following protocol: 95uC for
15 min, 40 cycles of 95uC for 20 sec, 43–58uC for 40 sec, 72uC for
30 sec, followed by an extension at 72uC for 10 min, and soaking
at 4uC. Following electrophoresis on a 1.5% agarose gel, the
remaining PCR products were cloned into bacteria (DH5a)b ya
pGEM T-Easy Vector System I (Promega, Madison, WI, USA).
DNA extracted from bacterial clones was analyzed via sequencing
with the M13 reverse primer (59-AGCGGATAACAATTTCA-
CACAGGA-39), using an ABI 3730XL capillary DNA sequencer
(Applied Biosystems, Foster City, CA, USA) and represented as
rows of circles, with each circle symbolizing the methylation state
of one CpG [31].
Evaluation of trans-differentiation properties of Oct4
overexpressed cells in vitro and in vivo BT mouse model
For the induction of neural differentiation, we cultured neuro-
spheres in a neurobasal medium (NB; Invitrogen, Gaithersburg,
MD, USA), supplemented with B27 (Invitrogen), 20 ng/ml of
bFGF, and 10 ng/ml of EGF (Sigma) for 4–7 days. The culture
density of the spheroid bodies was maintained at 20–50 cells/cm
2
to prevent self-aggregation. Then, neurospheres derived from the
cells were layered and cultured further on PDL-laminin double-
coated well plates. To determine the expression of the neural
markers, differentiated ATSC were fixed in 4% paraformaldehyde
(PFA) fixative solution for 30 minutes at room temperature. After
extensive washing in PBS, the cells were blocked for 30 minutes at
room temperature with 1% normal goat serum. The cells were
then incubated with primary antibodies against anti-TuJ1 (1:500;
Sigma) and anti-GFAP (1:1500; DAKO, USA). After extensive
washing, the cells were incubated with FITC or Texas-Red
conjugated secondary antibodies (1:250; Molecular Probes, USA).
We then analyzed the cells via fluorescence microscopy (Leica
Microsystems, PA, USA) [32].
Electrophysiological Recording
Electrophysiological evaluation (evoked action potential of
engrafted Oct4/ATSCs was performed before, immediately after
and 30 days after the sciatic taxonomy and Oct4/ATSCs
transplantation. Under anesthesia, the rat’s left sciatic nerve and
fourth digital nerve were exposed. Bipolar hooked platinum
recording and stimulating electrodes were used to induce and
record electrical activity. The stimulating electrode was placed
under the proximal sciatic nerve and the recording electrode was
placedunderthefourthdigitalnerve.Theevokedactionpotentialin
responding to the stimuli (one ms, 500 mV) in the ipsilateral sciatic
nerve was recorded using Powerlab-800 system (AD Instruments,
Colorado Springs, CO, http://www.adinstrumentsinc.com).
Oligonucleotide microarray and data analysis
Samples for gene array analysis were prepared from the total
RNA, and microarray analysis was conducted in accordance with
the manufacturer’s recommendations. Fragmented cRNA (15 mg)
was hybridized for 16 hours at 45uC to the Affymetrix HG-U95A
array for the comparison study (Affymetrix, Santa Clara, CA,
USA). After hybridization, the probe arrays were scanned at 3 mm
resolution using the Genechip System confocal scanner. The
output from the microarray analysis was merged with the Unigene
or Genebank descriptor and stored as an Excel (Microsoft Corp.,
Redmond, WA, USA) data spreadsheet. The definition of a 2-fold
change, or no change in the expression of individual genes was
predicated on the ranking of the difference call (DC) from two
comparisons (291), namely, no change (NC) of expression for
individual genes was merged with the Unigene or GeneBank
descriptor and stored as an Excel data spreadsheet. The
reproducibility of paired experiments was evaluated on the basis
of the coefficient of variation (CV; SD/mean) for fold change (FC).
The CV of FC must be #1.0. Finally, genes with a FC .2.0 were
considered to be significant. These cut-off values represented a
conservative estimate of the numbers of genes whose expression
levels differed between samples. Gene categorization was based on
a literature review. All microarray data in this study was described
in accordance with MIAME guidelines. And the resulting data
from DNA sequencing has been deposited in GeneBank and
include the accession numbers.
miRNA analysis
The miRNA assay probes correspond to 470 well annotated
human miRNA sequences (miRBase: http:// microrna.sanger.ac.
uk/, version 9.1, February 2007 Release) and 265 miRNAs
identified recently. To maximize assay specificity, candidate
probes were examined collectively to minimize sequence similarity
between probes, particularlyat their 39-ends. Briefly, 15 ul of the
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MSO pool (MAP, Illumina) and 30 ul of a reagent containing
streptavidin paramagnetic particles (OB1, Illumina), heated to
70uC, and allowed to anneal to 40uC. All 735 human miRNAs
were assayed simultaneously. After binding and washing, the
annealed MSOs were extended through the cDNA primer,
forming an amplifiable product. The extended oligos were eluted
from the streptavidin beads and added to a PCR reaction, in
which one of the universal primers was fluorescently labelled and
the other universal primer was biotinylated. The PCR products
were captured on streptavidin paramagnetic beads, washed and
denatured to yield single stranded fluorescent molecules to
hybridize to the arrays. The universal arrays used for fluorescent
reporting consist of capture oligos immobilized on beads and
randomly assembled into wells etched in sentrix universal bead
chip (1536 bead array). The identity of each bead is determined
before hybridization to the miRNA assay product, and the same
arrays are used to report the results of similar assays employing the
address sequence technique (GoldenGate_ Genotyping Assay,
DASL Gene Expression Assay, GoldenGate Methylation Assay).
Arrays were scanned on the BeadArray Reader, and automatic
image registration and intensity extraction software was used to
derive intensity data per bead type corresponding to each miRNA.
All microarray data in this study was described in accordance with
MIAME guidelines. And the resulting data from DNA sequencing
has been deposited in GeneBank and include the accession
numbers.
Statistical Analysis
All data were expressed as the means6SEM from five or more
independent experiments. The statistical significance of difference
between groups was calculated using Student’s two tailed t-test.
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